CDY 1.43% 7.1¢ cellmid limited

News: CDY Cellmid Says Sales For 2Q 2019 Expected To Reach $2.2 Million, page-19

  1. 1,439 Posts.
    lightbulb Created with Sketch. 49
    "Midkine Potential Announcements
    considering Cellmid is a Biotech may also be a good idea ."
    MJ the last investor presentation indicated that the company would complete pre-clinical development and file for orphan drug application in 2018 for,I think CAB102. There's not much of 2018 left but it would be a nice Christmas present if there was an announcement released.
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.